208 related articles for article (PubMed ID: 37175004)
1. A Comprehensive Pan-Cancer Analysis Identifies CEP55 as a Potential Oncogene and Novel Therapeutic Target.
Zaki MSA; Eldeen MA; Abdulsahib WK; Shati AA; Alqahtani YA; Al-Qahtani SM; Otifi HM; Asiri A; Hassan HM; Emam Mohammed Ahmed H; Dawood SA; Negm A; Eid RA
Diagnostics (Basel); 2023 May; 13(9):. PubMed ID: 37175004
[TBL] [Abstract][Full Text] [Related]
2. Cancer-testis antigen CEP55 serves as a prognostic biomarker and is correlated with immune infiltration and immunotherapy efficacy in pan-cancer.
Xie X; Liang H; Jiangting W; Wang Y; Ma X; Tan Z; Cheng L; Luo Z; Wang T
Front Mol Biosci; 2023; 10():1198557. PubMed ID: 37484531
[No Abstract] [Full Text] [Related]
3. CEP55 as a Promising Immune Intervention Marker to Regulate Tumor Progression: A Pan-Cancer Analysis with Experimental Verification.
Wang G; Chen B; Su Y; Qu N; Zhou D; Zhou W
Cells; 2023 Oct; 12(20):. PubMed ID: 37887301
[TBL] [Abstract][Full Text] [Related]
4. CEP55: an immune-related predictive and prognostic molecular biomarker for multiple cancers.
Li GS; Zhang W; Huang WY; He RQ; Huang ZG; Gan XY; Yang Z; Dang YW; Kong JL; Zhou HF; Chen G
BMC Pulm Med; 2023 May; 23(1):166. PubMed ID: 37173675
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of centrosomal protein 55 is associated with unfavorable prognosis and tumor invasion in epithelial ovarian carcinoma.
Zhang W; Niu C; He W; Hou T; Sun X; Xu L; Zhang Y
Tumour Biol; 2016 May; 37(5):6239-54. PubMed ID: 26615423
[TBL] [Abstract][Full Text] [Related]
6. High levels of centrosomal protein 55 expression is associated with poor clinical prognosis in patients with cervical cancer.
Qi J; Liu G; Wang F
Oncol Lett; 2018 Jun; 15(6):9347-9352. PubMed ID: 29805659
[TBL] [Abstract][Full Text] [Related]
7. Centrosomal Protein 55 (CEP55) Drives Immune Exclusion and Resistance to Immune Checkpoint Inhibitors in Colorectal Cancer.
Wangmo D; Gates TJ; Zhao X; Sun R; Subramanian S
Vaccines (Basel); 2024 Jan; 12(1):. PubMed ID: 38250876
[TBL] [Abstract][Full Text] [Related]
8. CEP55 promotes epithelial-mesenchymal transition in renal cell carcinoma through PI3K/AKT/mTOR pathway.
Chen H; Zhu D; Zheng Z; Cai Y; Chen Z; Xie W
Clin Transl Oncol; 2019 Jul; 21(7):939-949. PubMed ID: 30607788
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of CEP55 Predicts Dismal Prognosis in Patients with Liver Cancer.
Yang L; He Y; Zhang Z; Wang W
Biomed Res Int; 2020; 2020():4139320. PubMed ID: 32337246
[TBL] [Abstract][Full Text] [Related]
10. CEP55 Positively Affects Tumorigenesis of Esophageal Squamous Cell Carcinoma and Is Correlated with Poor Prognosis.
Yan SM; Liu L; Gu WY; Huang LY; Yang Y; Huang YH; Luo RZ
J Oncol; 2021; 2021():8890715. PubMed ID: 34104194
[TBL] [Abstract][Full Text] [Related]
11. Assessment of RACGAP1 as a Prognostic and Immunological Biomarker in Multiple Human Tumors: A Multiomics Analysis.
Eid RA; Soltan MA; Eldeen MA; Shati AA; Dawood SA; Eissa M; Zaki MSA; Algahtani M; Theyab A; Abdel-Daim MM; Kim B
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430577
[TBL] [Abstract][Full Text] [Related]
12. Expression and clinical significance of Centrosomal protein 55 (CEP55) in human urinary bladder transitional cell carcinoma.
Singh PK; Srivastava AK; Rath SK; Dalela D; Goel MM; Bhatt ML
Immunobiology; 2015 Jan; 220(1):103-8. PubMed ID: 25178936
[TBL] [Abstract][Full Text] [Related]
13. A pan-cancer analysis reveals CHD1L as a prognostic and immunological biomarker in several human cancers.
Soltan MA; Eldeen MA; Eid RA; Alyamani NM; Alqahtani LS; Albogami S; Jafri I; Park MN; Alsharif G; Fayad E; Mohamed G; Osman R; Kim B; Zaki MSA
Front Mol Biosci; 2023; 10():1017148. PubMed ID: 37033447
[No Abstract] [Full Text] [Related]
14. CEP55 3'-UTR promotes epithelial-mesenchymal transition and enhances tumorigenicity of bladder cancer cells by acting as a ceRNA regulating miR-497-5p.
Yang C; Yang Y; Wang W; Zhou W; Zhang X; Xiao Y; Zhang H
Cell Oncol (Dordr); 2022 Dec; 45(6):1217-1236. PubMed ID: 36374443
[TBL] [Abstract][Full Text] [Related]
15. Correlation between EZH2 and CEP55 and lung adenocarcinoma prognosis.
Wu S; Wu D; Pan Y; Liu H; Shao Z; Wang M
Pathol Res Pract; 2019 Feb; 215(2):292-301. PubMed ID: 30527357
[TBL] [Abstract][Full Text] [Related]
16. High CEP55 expression is associated with poor prognosis in non-small-cell lung cancer.
Jiang C; Zhang Y; Li Y; Lu J; Huang Q; Xu R; Feng Y; Yan S
Onco Targets Ther; 2018; 11():4979-4990. PubMed ID: 30154666
[TBL] [Abstract][Full Text] [Related]
17. CEP55 promotes cell proliferation and inhibits apoptosis via the PI3K/Akt/p21 signaling pathway in human glioma U251 cells.
Li F; Jin D; Tang C; Gao D
Oncol Lett; 2018 Apr; 15(4):4789-4796. PubMed ID: 29552118
[TBL] [Abstract][Full Text] [Related]
18. Expression and clinical significance of centrosomal protein 55 in T-cell lymphoma.
Xu Y; Zhou X; Li Y; Zhang Y; Wang X
J Cancer Res Ther; 2018 Jan; 14(1):94-98. PubMed ID: 29516967
[TBL] [Abstract][Full Text] [Related]
19. Centrosomal protein 55 activates NF-κB signalling and promotes pancreatic cancer cells aggressiveness.
Peng T; Zhou W; Guo F; Wu HS; Wang CY; Wang L; Yang ZY
Sci Rep; 2017 Jul; 7(1):5925. PubMed ID: 28724890
[TBL] [Abstract][Full Text] [Related]
20. Downstream targets of FOXM1: CEP55 and HELLS are cancer progression markers of head and neck squamous cell carcinoma.
Waseem A; Ali M; Odell EW; Fortune F; Teh MT
Oral Oncol; 2010 Jul; 46(7):536-42. PubMed ID: 20400365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
